06 August 2018
Visiongain’ has launched a new pharma report Global Single Use Bioprocessing Market to 2027: Bioreactors, Tangential Flow Devices, Depth Fillers, Disposable Filter Cartridges, Media bags Containers, Mixing Systems, Tubing Assemblies, Sampling Systems, Monoclonal Antibody Production, Vaccine Production
The Single Use Bioprocessing Market is set to experience strong growth over the forecast period. The primary factor boosting the demand of Single use bioprocessing technologies includes increase in adoption and commercial acceptance of single use technologies in commercial (GMP) product manufacture and growing demand for biopharmaceuticals.
By product, media bags & containers dominates the single use bioprocessing market. It occupies a share of around 23.5% share in the total global single use bioprocessing market. This is due to media bags & containers being available from various vendors and offer quality performance required for biopharmaceuticals manufacturing. Numerous technological advancements in bioreactor designs, stirring mechanisms, and sensor systems have led to rising rate of adoption of disposable reactors from the laboratory to production scale laboratories.
The lead analyst of the report commented “Asia-Pacific and Rest of the World (RoW) are the emerging single use bioprocessing markets. These regions hold tremendous potential to become the single use bioprocessing market giants in the future. Asia-Pacific countries are estimated to demonstrate tremendous growth for bioreactors owing to the massive expansion of the biopharmaceutical sector in this region.
The rising interest of pharmaceutical organizations to enter the biopharmaceutical market will result in consolidation in the form of strategic alliances between contract manufacturing organizations (CMO’s) and large pharmaceutical/biotechnology organizations. This will result in increased investments and access to cutting-edge manufacturing technologies for CMOs”
Leading companies featured in the report include Sartorius AG, Thermo Fisher Scientific, Inc., Merck KGaA, GE Healthcare, Danaher Corporation, Eppendorf AG, Applikon Biotechnology Inc., Solaris Biotech, Bioengineering AG, BBI- Biotech GmbH
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to firstname.lastname@example.org or call her on +44 (0) 207 336 6100
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-to-business reports cusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
Some of the major factors fuelling the growth of global market include significant advantages associated with PIM solutions and inclination towards centralized models among across pharma sector.
19 October 2020
The coronavirus outbreak has negatively impacted all the economies and industries across the globe. Hence, for the next 1-2 years, the global respiratory drug delivery market is expected to take a hit.
12 October 2020
We predict strong revenue growth through to 2030. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
02 October 2020
The development of mRNA vaccines is driven by new biotechnologies and nanotechnologies. Emerging delivery technologies, such as electroporation (EP), innovative vaccine formats like mRNA preventive boost, and new molecular adjuvant technologies are particularly important for mRNA vaccines reaching their potential.